Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curmune CZ is a nutraceutical combination product developed by Tigris Lifesciences, typically formulated as an oral tablet. It contains a synergistic blend of curcumin, ascorbic acid (Vitamin C), and zinc. Curcumin, the primary active polyphenol derived from turmeric (*Curcuma longa*), is known for its potent anti-inflammatory and antioxidant properties, primarily mediated through the inhibition of the Nuclear factor kappa B (NF-κB) signaling pathway and the direct scavenging of reactive oxygen species. Ascorbic acid serves as a vital water-soluble antioxidant and an essential cofactor for various enzymatic reactions, including those critical for immune cell function and collagen synthesis. Zinc is an essential trace mineral that plays a structural and regulatory role in numerous proteins and enzymes, supporting the maintenance of immune integrity and cellular defense mechanisms. The product is marketed to support overall immune health and reduce oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcumin + ascorbic acid + zinc.